Pelitinib (EKB-569)
Pelitinib is a pan-ErbB tyrosine kinase inhibitor with potential anticancer activity. Pelitinib irreversibly binds covalently to epidermal growth factor receptors (EGFR) ErbB-1, -2 and -4, thereby inhibiting receptor phosphorylation and signal transduction and resulting in apoptosis and suppression of proliferation in tumor cells that overexpress these receptors.
Product Specifications
Shipping Conditions
Gel pack
Storage Conditions
-20°C
Shelf Life
36 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6331265-01 0.2 mL
PBXIP1, CT (PBXIP1, HPIP, Pre-B Cell leukemia transcription factor-interacting protein 1, Hematopoietic PBX-interacting protein) (APC)
Sign In for Pricing
View Details MBS6331265-02 5x 0.2 mL
PBXIP1, CT (PBXIP1, HPIP, Pre-B Cell leukemia transcription factor-interacting protein 1, Hematopoietic PBX-interacting protein) (APC)
Sign In for Pricing
View Details 
E8530-10-FITC 200 µL
ETNK1, NT (Ethanolamine Kinase 1, EKI 1, EKI1) (FITC) discontinued
Sign In for Pricing
View Details